Page last updated: 2024-10-22

amifostine anhydrous and Allodynia

amifostine anhydrous has been researched along with Allodynia in 2 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Pereira, AF1
Lino, JA1
Alves, BWF1
Lisboa, MRP1
Pontes, RB1
Leite, CAVG1
Nogueira, RB1
Lima-JĂșnior, RCP1
Vale, ML1
Kowalski, T1
Maier, C1
Reinacher-Schick, A1
Schlegel, U1

Reviews

1 review available for amifostine anhydrous and Allodynia

ArticleYear
[Painful hyperexcitability syndrome with oxaliplatin containing chemotherapy. Clinical features, pathophysiology and therapeutic options].
    Schmerz (Berlin, Germany), 2008, Volume: 22, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Amifostine; Animals; Antineoplastic Agents; Antineoplastic Combined Ch

2008

Other Studies

1 other study available for amifostine anhydrous and Allodynia

ArticleYear
Amifostine protects from the peripheral sensory neuropathy induced by oxaliplatin in mice.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2020, Volume: 53, Issue:11

    Topics: Amifostine; Animals; Antineoplastic Agents; Hyperalgesia; Male; Mice; Oxaliplatin; Peripheral Nervou

2020